Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urticaria Pigmentosa | 1 | 2019 | 5 | 0.720 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2017 | 9 | 0.610 |
Why?
|
| Infant, Newborn | 21 | 2022 | 2453 | 0.590 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 88 | 0.580 |
Why?
|
| Cytomegalovirus Infections | 1 | 2017 | 69 | 0.570 |
Why?
|
| Neonatology | 4 | 2010 | 29 | 0.550 |
Why?
|
| Glucocorticoids | 1 | 2017 | 222 | 0.530 |
Why?
|
| Antiviral Agents | 1 | 2017 | 211 | 0.510 |
Why?
|
| Kangaroo-Mother Care Method | 1 | 2013 | 9 | 0.480 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 514 | 0.450 |
Why?
|
| Education, Medical, Graduate | 2 | 2014 | 214 | 0.430 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 239 | 0.420 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2001 | 123 | 0.350 |
Why?
|
| Teaching | 1 | 2010 | 169 | 0.340 |
Why?
|
| Internship and Residency | 2 | 2014 | 596 | 0.330 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2006 | 46 | 0.260 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2019 | 91 | 0.240 |
Why?
|
| Kernicterus | 1 | 2002 | 7 | 0.220 |
Why?
|
| Jaundice, Neonatal | 1 | 2002 | 8 | 0.220 |
Why?
|
| Infant, Premature, Diseases | 1 | 2022 | 85 | 0.200 |
Why?
|
| Intensive Care, Neonatal | 1 | 2001 | 38 | 0.200 |
Why?
|
| Premature Birth | 1 | 2022 | 148 | 0.190 |
Why?
|
| Down Syndrome | 1 | 2001 | 119 | 0.180 |
Why?
|
| Administration, Inhalation | 4 | 2006 | 187 | 0.170 |
Why?
|
| Mosaicism | 1 | 1998 | 21 | 0.160 |
Why?
|
| Humans | 24 | 2022 | 68525 | 0.160 |
Why?
|
| Trisomy | 1 | 1998 | 47 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1998 | 54 | 0.160 |
Why?
|
| Prenatal Diagnosis | 1 | 1998 | 73 | 0.150 |
Why?
|
| Biopsy | 1 | 2019 | 539 | 0.150 |
Why?
|
| Diagnostic Errors | 1 | 1998 | 100 | 0.150 |
Why?
|
| Ganciclovir | 1 | 2017 | 27 | 0.150 |
Why?
|
| Etoposide | 1 | 2017 | 64 | 0.150 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2017 | 42 | 0.150 |
Why?
|
| Birth Weight | 4 | 2006 | 186 | 0.150 |
Why?
|
| Infant, Extremely Premature | 1 | 2017 | 18 | 0.150 |
Why?
|
| Nitric Oxide | 3 | 2006 | 382 | 0.150 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 596 | 0.150 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 94 | 0.150 |
Why?
|
| Cyclosporine | 1 | 2017 | 121 | 0.140 |
Why?
|
| Bone Marrow | 1 | 2017 | 168 | 0.140 |
Why?
|
| Dexamethasone | 1 | 2017 | 150 | 0.140 |
Why?
|
| Trachea | 2 | 1993 | 48 | 0.140 |
Why?
|
| Infant | 5 | 2017 | 2891 | 0.140 |
Why?
|
| Muscle, Smooth | 2 | 1993 | 117 | 0.140 |
Why?
|
| Delivery, Obstetric | 1 | 1995 | 58 | 0.130 |
Why?
|
| Aerosols | 1 | 1995 | 42 | 0.130 |
Why?
|
| Neonatal Nursing | 1 | 1995 | 16 | 0.130 |
Why?
|
| Cesarean Section | 1 | 1995 | 101 | 0.130 |
Why?
|
| Hypernatremia | 1 | 1994 | 7 | 0.120 |
Why?
|
| Sodium Chloride | 1 | 1994 | 136 | 0.120 |
Why?
|
| False Positive Reactions | 1 | 2013 | 95 | 0.120 |
Why?
|
| Bronchial Hyperreactivity | 1 | 1993 | 10 | 0.110 |
Why?
|
| Consensus | 1 | 2014 | 211 | 0.110 |
Why?
|
| Chylous Ascites | 1 | 1990 | 11 | 0.100 |
Why?
|
| Persistent Fetal Circulation Syndrome | 2 | 2001 | 15 | 0.100 |
Why?
|
| Ascites | 1 | 1990 | 38 | 0.100 |
Why?
|
| Health Care Sector | 1 | 2010 | 26 | 0.100 |
Why?
|
| Pediatrics | 1 | 2014 | 341 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1990 | 79 | 0.090 |
Why?
|
| Fetal Diseases | 1 | 1990 | 64 | 0.090 |
Why?
|
| Infant Mortality | 1 | 1990 | 59 | 0.090 |
Why?
|
| Female | 10 | 2022 | 38015 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 1990 | 149 | 0.090 |
Why?
|
| Gentamicins | 1 | 1989 | 68 | 0.090 |
Why?
|
| Health Services Research | 1 | 1990 | 209 | 0.080 |
Why?
|
| Male | 9 | 2017 | 37281 | 0.080 |
Why?
|
| Infant, Low Birth Weight | 2 | 2022 | 84 | 0.080 |
Why?
|
| Pregnancy | 4 | 2022 | 2331 | 0.080 |
Why?
|
| Lung Diseases | 2 | 2006 | 175 | 0.070 |
Why?
|
| Aging | 1 | 1993 | 911 | 0.070 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2006 | 34 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2017 | 7028 | 0.070 |
Why?
|
| Furosemide | 2 | 1994 | 45 | 0.060 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2003 | 16 | 0.060 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2002 | 10 | 0.050 |
Why?
|
| Radiation Protection | 1 | 2003 | 71 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2003 | 138 | 0.050 |
Why?
|
| Bezoars | 1 | 2001 | 3 | 0.050 |
Why?
|
| Blood Gas Analysis | 1 | 2002 | 41 | 0.050 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2001 | 5 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2002 | 46 | 0.050 |
Why?
|
| Infant Food | 1 | 2001 | 16 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2002 | 43 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 1 | 2003 | 208 | 0.050 |
Why?
|
| Hypoglycemia | 1 | 2002 | 72 | 0.050 |
Why?
|
| Physician's Role | 1 | 2002 | 116 | 0.050 |
Why?
|
| Hospitals, University | 1 | 2002 | 169 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2002 | 101 | 0.050 |
Why?
|
| Gestational Age | 1 | 2022 | 389 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2002 | 114 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2003 | 232 | 0.050 |
Why?
|
| Point-of-Care Systems | 1 | 2002 | 115 | 0.050 |
Why?
|
| Genotype | 1 | 2002 | 785 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2000 | 76 | 0.040 |
Why?
|
| Risk Factors | 2 | 2002 | 5719 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 772 | 0.040 |
Why?
|
| Guinea Pigs | 2 | 1993 | 124 | 0.040 |
Why?
|
| Histamine | 2 | 1993 | 52 | 0.030 |
Why?
|
| Mass Screening | 1 | 2002 | 837 | 0.030 |
Why?
|
| Acetylcholine | 2 | 1993 | 64 | 0.030 |
Why?
|
| Apgar Score | 1 | 1995 | 22 | 0.030 |
Why?
|
| Prognosis | 1 | 2001 | 2093 | 0.030 |
Why?
|
| Maternal Age | 1 | 1995 | 70 | 0.030 |
Why?
|
| Achievement | 1 | 2014 | 22 | 0.030 |
Why?
|
| Specialty Boards | 1 | 2014 | 24 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 1994 | 43 | 0.030 |
Why?
|
| Competency-Based Education | 1 | 2014 | 32 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 334 | 0.030 |
Why?
|
| Drug Overdose | 1 | 1994 | 67 | 0.030 |
Why?
|
| Isometric Contraction | 1 | 1993 | 33 | 0.030 |
Why?
|
| Epithelium | 1 | 1993 | 172 | 0.030 |
Why?
|
| Medication Errors | 1 | 1994 | 116 | 0.030 |
Why?
|
| Bronchi | 1 | 1992 | 59 | 0.030 |
Why?
|
| Respiration, Artificial | 2 | 2006 | 190 | 0.030 |
Why?
|
| Infant, Premature | 2 | 2006 | 284 | 0.030 |
Why?
|
| United States | 2 | 2014 | 7335 | 0.030 |
Why?
|
| Hydrops Fetalis | 1 | 1990 | 1 | 0.020 |
Why?
|
| Intestinal Perforation | 1 | 1991 | 35 | 0.020 |
Why?
|
| Insulin | 1 | 1994 | 617 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 1992 | 211 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1992 | 317 | 0.020 |
Why?
|
| Appendicitis | 1 | 1991 | 55 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1991 | 1139 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 1992 | 323 | 0.020 |
Why?
|
| Georgia | 1 | 1990 | 161 | 0.020 |
Why?
|
| Curriculum | 1 | 2014 | 575 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 1989 | 65 | 0.020 |
Why?
|
| Cause of Death | 1 | 1990 | 241 | 0.020 |
Why?
|
| Cohort Studies | 1 | 1995 | 2356 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2014 | 657 | 0.020 |
Why?
|
| Creatinine | 1 | 1989 | 243 | 0.020 |
Why?
|
| Fetus | 2 | 2002 | 157 | 0.020 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2006 | 4 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2006 | 80 | 0.020 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2006 | 69 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 1745 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2006 | 714 | 0.020 |
Why?
|
| Miniaturization | 1 | 2003 | 21 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2003 | 121 | 0.010 |
Why?
|
| Anemia, Neonatal | 1 | 2002 | 6 | 0.010 |
Why?
|
| Convalescence | 1 | 2002 | 11 | 0.010 |
Why?
|
| Apnea | 1 | 2002 | 16 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 2002 | 29 | 0.010 |
Why?
|
| Catheterization | 1 | 2003 | 209 | 0.010 |
Why?
|
| Hematocrit | 1 | 2002 | 70 | 0.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2002 | 72 | 0.010 |
Why?
|
| Stomach | 1 | 2001 | 80 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 307 | 0.010 |
Why?
|
| Time Factors | 2 | 2003 | 4655 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 1055 | 0.010 |
Why?
|
| Equipment Design | 1 | 2002 | 500 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2003 | 419 | 0.010 |
Why?
|
| Milk, Human | 1 | 2001 | 147 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2000 | 249 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2002 | 631 | 0.010 |
Why?
|
| Animals | 2 | 1993 | 20877 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 3256 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 2077 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 1329 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2001 | 3185 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1992 | 137 | 0.010 |
Why?
|
| Adult | 1 | 1990 | 21375 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1992 | 276 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1992 | 396 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1992 | 765 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1991 | 21 | 0.010 |
Why?
|
| Radiography | 1 | 1991 | 572 | 0.010 |
Why?
|
| Age Factors | 1 | 1992 | 1860 | 0.000 |
Why?
|